Healthcare & Life Sciences

Tacit Therapeutics

series-a
series-a
Stage
1
Investors

About

Tacit Therapeutics develops RNA-based therapies using synthetic biology techniques to address significant medical conditions.

Explore Tacit Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.